Skip to content

Clinical Observation of Zihua Xiaoying Decoction in Treating Hashimoto Thyroiditis with Thyroid Nodules of Phlegm and Blood Stasis Type Clinical Observation of Zihua Xiaoying Decoction in Treating Hashimoto Thyroiditis with Thyroid Nodules of Phlegm and Blood Stasis Type

Clinical Observation of Zihua Xiaoying Decoction in Treating Hashimoto Thyroiditis with Thyroid Nodules of Phlegm and Blood Stasis Type Clinical Observation of Zihua Xiaoying Decoction in Treating Hashimoto Thyroiditis with Thyroid Nodules of Phlegm and Blood Stasis Type

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047043
Enrollment
Unknown
Registered
2021-06-07
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hashimoto's thyroiditis with thyroid nodules

Interventions

Sponsors

Weishan People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. It conforms to the diagnosis of Hashimoto's thyroiditis complicated with thyroid nodules; 2. It conforms to the dialectical standard of "phlegm and blood stasis syndrome" of traditional Chinese medicine; 3. Aged 18 to 70 years, gender is not limited; 4. Informed consent.

Exclusion criteria

Exclusion criteria: 1. Hashimoto's thyroiditis in hyperthyroidism stage; 2. Patients with obvious compression symptoms caused by goiter or confirmed thyroid cancer; 3. Patients with clinical hyperthyroidism or hypothyroidism caused by other reasons ; 4. Patients with serious diseases such as cardiovascular and cerebrovascular diseases, liver and kidney; 5. Patients with mental and psychological disorders ; 6. Patients with allergic history of traditional Chinese medicine or proprietary Chinese medicine; 7. Patients who are participating in clinical research of other drugs ; 8. Pregnant women and lactating women.

Design outcomes

Primary

MeasureTime frame
Thyroid color Doppler ultrasound;Thyroid peroxidase antibody;Thyroglobulin antibody;Thyroid function;

Countries

China

Contacts

Public ContactLi Xiaoe

Weishan People's Hospital

361925650@qq.com+86 15315378176

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026